Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfotep SCHEMBL3045588 | 0.85 | RECQL (0.30) | RECQL | |
| SCHEMBL2053507 | 0.84 | RECQL (0.42) | RECQL | |
| SCHEMBL22717361 | 0.83 | DGKA (0.44) | RECQL | |
| SCHEMBL2305604 | 0.81 | KDM6B (0.31) | RECQL | |
| SCHEMBL2775882 | 0.80 | RECQL (0.33) | RECQL | |
| SCHEMBL8861555 | 0.79 | RECQL (0.32) | RECQL | |
| SCHEMBL2726401 | 0.78 | RECQL (0.30) | RECQL | |
| SCHEMBL1580299 | 0.78 | TSHR (0.35) | RECQL | |
| SCHEMBL22284784 | 0.76 | PRKCA (0.47) | — | |
| SCHEMBL9980489 | 0.76 | NAAA (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119816334-A | Sealant for tissue closure | 爱惜康股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118549505-A | Electrochemical biosensor and preparation method and application thereof | 上海联影微电子科技有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118340745-A | GSH response nanoparticle with high biocompatibility and high siRNA delivery efficiency and preparation method thereof | 复旦大学 | 2024-07-16 | — | — | CN | claimed |
| CN-117568277-A | Separation method for constructing breast cancer cell-derived exosomes based on microfluidic device | 重庆医科大学附属第三医院(捷尔医院） | 2024-02-20 | — | — | CN | claimed |
| CN-117264238-A | Self-repairing hydrogel with acylhydrazone bond and disulfide bond and preparation method thereof | 陕西科技大学 | 2023-12-22 | — | — | CN | claimed |
| CN-116726161-A | Albumin delivery system loaded with antigen polypeptide and preparation method and application thereof | 杭州星肽原生物技术有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116194146-A | Compositions for delivery of bioactive agents, methods of manufacture and uses thereof | 詹正雄 | 2023-05-30 | — | — | CN | claimed |
| CN-116068167-A | Separation and detection method of extracellular biomacromolecule | 厦门福流生物科技有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-115896055-A | High-titer CP4-EPSPS antigen and application thereof | 李锦记（新会）食品有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-115181292-A | Structural color multi-response hydrogel and preparation method and application thereof | 仲恺农业工程学院 | 2022-10-14 | — | — | CN | claimed |
| US-8217154-B2 | Biodrug delivery | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2012-07-10 | — | — | US | claimed |
| US-20080262209-A1 | Activated Sialic Acid Derivatives for Protein Derivatisation and Conjugation | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2008-10-23 | — | — | US | claimed |
| US-20070282096-A1 | amine or hydrazide derivatives; for conjugation to proteins, drugs, drug delivery systems | OPKO PHARMACEUTICALS, LLC | 2007-12-06 | — | — | US | claimed |
| EP-1853634-A1 | ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION | Lipoxen Technologies Limited (GB) | 2007-11-14 | — | — | EP | claimed |
| EP-1776389-A2 | SIALIC ACID DERIVATIVES | Lipoxen Technologies Limited (GB) | 2007-04-25 | — | — | EP | claimed |
| WO-2006090119-A1 | ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2006-08-31 | — | — | WO | claimed |
| WO-2006016168-A2 | SIALIC ACID DERIVATIVES | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2006-02-16 | — | — | WO | claimed |
| EP-0876166-B1 | USE OF INJECTABLE OR IMPLANTABLE BIOMATERIALS FOR FILLING OR BLOCKING LUMENS AND VOIDS OF THE BODY | COHESION TECH INC (US) | 2004-08-18 | — | — | EP | claimed |
| WO-1997043645-A1 | ANTIBODIES DIRECTED AGAINST DITHIOCARBAMATES | MEDINOX, INC. (US) | 1997-11-20 | — | — | WO | claimed |
| US-4970298-A | WOUND HEALING AGENTS, CROSSLINKED COLLAGEN SPONGE | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1990-11-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262209-A1 | Activated Sialic Acid Derivatives for Protein Derivatisation and Conjugation | NANS, SPAST, NEU1 | RECQL 4834/4885 |
| US-20070282096-A1 | amine or hydrazide derivatives; for conjugation to proteins, drugs, drug delivery systems | HPSE, CD44, GNE | RECQL 4008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.